Competitors of Suven Life Sciences Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,575 Cr. | 328 | 390/108 | 67.8 | 20.5 | 0.20 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 57.4 Cr. | 77.4 | 94.9/25.8 | 22.0 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 27.8 Cr. | 19.0 | 19.5/8.35 | 36.1 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
| Godavari Drugs Ltd | 88.4 Cr. | 117 | 155/87.0 | 13.2 | 55.4 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 13,347 Cr. | 1,093 | 1,335/625 | 31.5 | 207 | 2.06 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 443 Cr. | 19.5 | 29.0/13.2 | 25.6 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.25 Cr. | 15.0 | 28.5/13.1 | 145 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 333 Cr. | 708 | 1,054/650 | 18.8 | 278 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
| Fervent Synergies Ltd | 50.2 Cr. | 16.7 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 1,091 Cr. | 371 | 374/145 | 133 | 98.6 | 0.34 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 5.88 Cr. | 28.0 | 43.8/23.6 | 118 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 18.2 Cr. | 7.33 | 19.4/7.21 | 40.6 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 114 Cr. | 143 | 184/110 | 50.6 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 153 Cr. | 2.20 | 3.10/0.98 | 207 | 3.80 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 17.2 Cr. | 7.15 | 14.5/6.40 | 15.8 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 15.4 Cr. | 15.2 | 25.8/14.4 | 18.5 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 273 Cr. | 766 | 999/345 | 11.8 | 570 | 0.26 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 36.0 Cr. | 36.0 | 61.5/30.6 | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 | |
| Colinz Laboratories Ltd | 24.5 Cr. | 53.5 | 84.4/36.0 | 44.5 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 11.6 Cr. | 4.63 | 26.5/4.12 | 46.3 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.8 Cr. | 78.8 | 94.7/40.4 | 9.46 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.47 Cr. | 13.6 | 17.4/4.09 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 54.3 Cr. | 72.0 | 160/63.0 | 34.4 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.42 Cr. | 21.4 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 102 Cr. | 23.6 | 43.9/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 16.5 Cr. | 32.5 | 46.0/20.2 | 48.5 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 233 Cr. | 404 | 412/175 | 24.0 | 110 | 1.11 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 26.1 Cr. | 44.3 | 50.0/4.68 | 66.9 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 72,762 Cr. | 1,242 | 1,593/958 | 20.0 | 527 | 0.36 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 129 Cr. | 207 | 307/112 | 21.0 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 997 Cr. | 199 | 265/140 | 16.9 | 60.5 | 1.26 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 58.6 Cr. | 44.9 | 86.1/43.5 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 8,767 Cr. | 2,145 | 2,185/1,004 | 93.9 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 6.60 Cr. | 1.00 | 1.20/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 435 Cr. | 56.7 | 77.7/37.5 | 32.6 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 14.6 Cr. | 25.0 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 126 Cr. | 74.8 | 82.5/40.2 | 191 | 18.5 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
| Abbott India Ltd | 59,026 Cr. | 27,758 | 30,521/21,983 | 46.0 | 1,657 | 1.48 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,742 Cr. | 636 | 722/381 | 25.2 | 205 | 0.47 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 151 Cr. | 55.0 | 75.8/37.0 | 21.9 | 47.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
| Zota Health Care Ltd | 1,540 Cr. | 562 | 725/402 | 58.0 | 0.18 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 21,083 Cr. | 1,295 | 1,335/323 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 751 Cr. | 226 | 291/100 | 27.2 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 11.0 % | 268 % | 2.00 | |
| Venus Remedies Ltd | 393 Cr. | 295 | 430/280 | 17.8 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 6,026 Cr. | 854 | 950/401 | 120 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 2,106 Cr. | 1,501 | 1,923/1,232 | 32.6 | 735 | 0.67 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,10,431 Cr. | 3,267 | 3,591/2,025 | 63.5 | 222 | 0.86 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,715 Cr. | 295 | 317/156 | 51.2 | 44.8 | 0.17 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,840 Cr. | 19.6 | 27.9/10.5 | 57.9 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 32,959 Cr. | 1,294 | 1,359/585 | 136 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,596 Cr. | 119 | 169/74.5 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,31,016 Cr. | 1,799 | 1,960/1,184 | 38.5 | 288 | 0.75 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 3,396 Cr. | 785 | 851/292 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 2,082 Cr. | 246 | 398/113 | 35.5 | 70.6 | 0.16 % | 11.2 % | 9.27 % | 1.00 |
| SMS Lifesciences India Ltd | 319 Cr. | 1,053 | 1,750/487 | 15.7 | 621 | 0.14 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 8,791 Cr. | 897 | 960/313 | 153 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 5,065 Cr. | 202 | 241/91.8 | 238 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 14,304 Cr. | 6,210 | 7,600/4,606 | 33.9 | 298 | 2.69 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,326 Cr. | 2,005 | 2,977/1,290 | 38.2 | 229 | 0.80 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,536 Cr. | 5,140 | 5,836/4,637 | 37.7 | 324 | 1.17 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 249 Cr. | 70.5 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 24,074 Cr. | 5,259 | 6,453/3,950 | 39.3 | 820 | 0.67 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 360 Cr. | 292 | 325/190 | 19.7 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,614 Cr. | 426 | 430/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 7,686 Cr. | 1,516 | 1,592/557 | 64.6 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 19,058 Cr. | 14,854 | 16,561/4,926 | 72.2 | 1,087 | 0.09 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 730 Cr. | 33.0 | 56.5/26.2 | 68.0 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,476 Cr. | 1,365 | 1,639/752 | 12.6 | 399 | 0.70 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,051 Cr. | 74.0 | 101/38.6 | 30.9 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 14,304 Cr. | 316 | 329/126 | 41.3 | 50.3 | 0.19 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 165 Cr. | 106 | 145/85.2 | 17.5 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 521 Cr. | 147 | 173/97.9 | 164 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
| Lupin Ltd | 96,192 Cr. | 2,107 | 2,312/1,200 | 36.6 | 343 | 0.38 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,234 Cr. | 616 | 814/498 | 12.8 | 319 | 0.29 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 28,694 Cr. | 532 | 536/359 | 122 | 79.2 | 0.15 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 884 Cr. | 852 | 961/356 | 25.7 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 211 Cr. | 97.8 | 122/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,062 Cr. | 220 | 370/198 | 20.1 | 103 | 1.36 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 494 Cr. | 307 | 470/298 | 35.2 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
| Jubilant Pharmova Ltd | 17,711 Cr. | 1,112 | 1,310/409 | 62.2 | 373 | 0.45 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 27,250 Cr. | 1,754 | 2,030/1,371 | 44.6 | 207 | 0.70 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,779 Cr. | 671 | 687/270 | 66.5 | 74.4 | 0.75 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 40,774 Cr. | 1,607 | 1,709/1,041 | 65.4 | 264 | 0.25 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,071 Cr. | 353 | 538/331 | 20.7 | 283 | 1.42 % | 12.3 % | 8.68 % | 10.0 |
| Indoco Remedies Ltd | 2,971 Cr. | 322 | 417/286 | 133 | 118 | 0.47 % | 10.4 % | 8.33 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 41,713 Cr. | 1,478 | 1,831/764 | 299 | 0.17 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 40,857 Cr. | 2,412 | 3,088/1,616 | 51.0 | 98.7 | 1.33 % | 51.3 % | 37.3 % | 10.0 |
| Dr Reddys Laboratories Ltd | 1,01,332 Cr. | 1,214 | 1,421/1,074 | 19.0 | 369 | 0.66 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,582 Cr. | 228 | 283/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,20,049 Cr. | 1,486 | 1,702/1,188 | 26.1 | 351 | 0.87 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,927 Cr. | 1,964 | 2,177/1,178 | 30.3 | 334 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 367 Cr. | 140 | 186/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,385 Cr. | 132 | 150/92.2 | 15.7 | 96.0 | 0.38 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 96.3 Cr. | 59.2 | 92.0/42.6 | 182 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 39,800 Cr. | 332 | 396/231 | 27.6 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 2,004 Cr. | 2,085 | 2,326/1,060 | 48.9 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 218 Cr. | 137 | 158/89.0 | 28.6 | 43.2 | 0.87 % | 12.1 % | 11.1 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 189 Cr. | 80.0 | 113/73.2 | 246 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 15,800 Cr. | 6,320 | 8,140/4,050 | 123 | 272 | 0.38 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,023 Cr. | 700 | 863/556 | 42.6 | 103 | 0.66 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 233 Cr. | 111 | 145/69.9 | 11.2 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 66,757 Cr. | 5,583 | 6,440/4,407 | 30.7 | 961 | 0.72 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 20,479 Cr. | 1,042 | 1,304/715 | 32.2 | 249 | 1.06 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 725 Cr. | 1,269 | 1,754/911 | 10.6 | 724 | 0.91 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 36,975 Cr. | 2,960 | 3,486/1,850 | 42.3 | 294 | 1.22 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 4,099 Cr. | 366 | 571/325 | 28.0 | 120 | 1.39 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,130 Cr. | 449 | 635/430 | 33.0 | 126 | 0.22 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,580.39 Cr | 1,198.24 | 56.22 | 184.90 | 0.32% | 16.36% | 16.88% | 6.61 |
